Osteonecrosis of the Jaw in a Patient Receiving Bisphosphonate Therapy
- 1 January 2007
- journal article
- case report
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 34 (2) , 301-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Systematic Review: Bisphosphonates and Osteonecrosis of the JawsAnnals of Internal Medicine, 2006
- Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With CancerJournal of Oncology Practice, 2006
- Osteonecrosis of the jaw associated with pamidronate therapyAmerican Journal of Hematology, 2005
- Managing the care of patients with bisphosphonate-associated osteonecrosisThe Journal of the American Dental Association, 2005
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and TreatmentJournal of Oral and Maxillofacial Surgery, 2005
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Bisphosphonate Osteochemonecrosis (Bis-Phossy Jaw): Is This Phossy Jaw of the 21st Century?Journal of Oral and Maxillofacial Surgery, 2005
- Pathogenesis and natural history of osteonecrosisSeminars in Arthritis and Rheumatism, 2002
- Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic AcidThe Journal of Pharmacology and Experimental Therapeutics, 2002